Cynosure Uk Ltd

Cynosure Uk Ltd, based in London, is a small holding company with an active status, celebrating 25 years since its founding in 1999. The company employs 34 people and boasts assets of £10,931,662. It has a real address and is managed by two directors and one owner. Cynosure Uk Ltd regularly imports and exports optical and medical tools and devices, with 183 months of import activity and 67 months of export activity recorded.

The company operates in the retail sale of medical and orthopaedic goods in specialised stores, and its website, while not provided, suggests a focus on this sector. It's a small company, meeting two of three conditions: turnover less than £10.2 million, balance sheet total less than £5.1 million, and fewer than 50 employees.

Financial data reveals a mixed picture. While cash bank on hand increased significantly by 150% to £1.8 million, trade debtors decreased by 28% to £2.2 million. Creditors also decreased by 23% to £6.5 million. Net assets grew by 14% to £4.9 million, but future minimum lease payments under non-operating leases increased dramatically by 120% to £1.7 million. The company's net current assets and liabilities increased by 17% to £4.4 million. It’s worth noting that the company’s depreciation impairment property plant equipment decreased by 53% for land and buildings, and by 50% for other property plant equipment.

The company's tax expense is based on taxable profit, and the accounts are unaudited, which is common for small companies. The immediate parent company is Cynosure, LLC, based in the United States. The company’s financial statements were prepared in accordance with FRS 102, and the accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Registered in England/Wales under the registration number 03841792, with a registered address at W4 4AJ, England, London, 17th Floor Chiswick Tower, 389 High Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.